1	The	The	B-NP	DT	O	10	NMOD	-1
2	Down	Down	I-NP	NNP	B-DNA	10	NMOD	-1
3	syndrome	syndrome	I-NP	NN	I-DNA	10	NMOD	-1
4	critical	critical	I-NP	JJ	I-DNA	10	NMOD	0
5	region	region	I-NP	NN	I-DNA	10	NMOD	-1
6	gene	gene	I-NP	NN	I-DNA	10	NMOD	-1
7	1	1	I-NP	CD	I-DNA	10	NMOD	-1
8	short	short	I-NP	JJ	I-DNA	10	NMOD	-1
9	variant	variant	I-NP	JJ	I-DNA	10	NMOD	-1
10	promoters	promoter	I-NP	NNS	I-DNA	11	SUB	-1
11	direct	direct	B-VP	VBP	O	0	ROOT	-1
12	vascular	vascular	B-NP	JJ	B-DNA	15	NMOD	-1
13	bed-specific	bed-specific	I-NP	JJ	I-DNA	15	NMOD	-1
14	gene	gene	I-NP	NN	I-DNA	15	NMOD	-1
15	expression	expression	I-NP	NN	O	11	OBJ	0
16	during	during	B-PP	IN	O	11	VMOD	-1
17	inflammation	inflammation	B-NP	NN	O	16	PMOD	-1
18	in	in	B-PP	IN	O	11	VMOD	-1
19	mice	mouse	B-NP	NNS	O	18	PMOD	-1
20	.	.	O	.	O	11	P	-1

1	Down	Down	B-NP	JJ	O	5	NMOD	-1
2	syndrome	syndrome	I-NP	NN	O	5	NMOD	-1
3	critical	critical	I-NP	JJ	O	5	NMOD	0
4	region	region	I-NP	NN	O	5	NMOD	-1
5	gene	gene	I-NP	NN	O	11	NMOD	-1
6	1	1	I-NP	CD	O	5	NMOD	-1
7	(	(	O	(	O	9	DEP	-1
8	DSCR-1	DSCR-1	B-NP	NN	B-protein	9	DEP	-1
9	)	)	I-NP	)	O	5	NMOD	-1
10	short	short	I-NP	JJ	O	11	NMOD	-1
11	variant	variant	I-NP	NN	O	15	SUB	-1
12	(	(	O	(	O	14	DEP	-1
13	DSCR-1s	DSCR-1	B-NP	NNS	B-protein	14	DEP	-1
14	)	)	O	)	O	11	NMOD	-1
15	is	be	B-VP	VBZ	O	0	ROOT	-1
16	an	an	B-NP	DT	O	17	NMOD	-1
17	inhibitor	inhibitor	I-NP	NN	O	15	PRD	0
18	of	of	B-PP	IN	O	17	NMOD	-1
19	calcineurin/NFAT	calcineurin/NFAT	B-NP	NN	B-protein	20	NMOD	-1
20	signaling	signaling	I-NP	NN	O	18	PMOD	0
21	encoded	encode	B-VP	VBN	O	20	NMOD	-1
22	by	by	B-PP	IN	O	21	VMOD	-1
23	exons	exon	B-NP	NNS	B-DNA	22	PMOD	-1
24	4-7	4-7	B-NP	CD	I-DNA	23	NMOD	-1
25	of	of	B-PP	IN	O	23	NMOD	-1
26	DSCR1	DSCR1	B-NP	NN	B-protein	25	PMOD	-1
27	.	.	O	.	O	15	P	-1

1	We	We	B-NP	PRP	O	3	SUB	-1
2	previously	previously	B-ADVP	RB	O	3	VMOD	-1
3	reported	report	B-VP	VBD	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	VEGF	VEGF	B-NP	NN	B-protein	6	SUB	-1
6	induces	induce	B-VP	VBZ	O	4	SBAR	17	induces
7	DSCR-1s	DSCR-1	B-NP	NNS	B-protein	8	NMOD	-1
8	expression	expression	I-NP	NN	O	6	OBJ	9	expression
9	in	in	B-PP	IN	O	8	NMOD	-1
10	endothelial	endothelial	B-NP	JJ	B-cell_type	11	NMOD	-1
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	-1
12	,	,	O	,	O	11	P	-1
13	which	which	B-NP	WDT	O	11	NMOD	-1
14	in	in	B-PP	IN	O	17	VMOD	-1
15	turn	turn	B-NP	NN	O	14	PMOD	-1
16	negatively	negatively	B-ADVP	RB	O	17	VMOD	-1
17	feeds	feed	B-VP	VBZ	O	13	SBAR	-1
18	back	back	B-ADVP	RB	O	17	VMOD	-1
19	to	to	B-VP	TO	O	20	VMOD	-1
20	attenuate	attenuate	I-VP	VB	O	17	VMOD	18	attenuate
21	endothelial	endothelial	B-NP	JJ	O	23	NMOD	-1
22	cell	cell	I-NP	NN	O	23	NMOD	-1
23	activation	activation	I-NP	NN	O	20	OBJ	17	activation
24	.	.	O	.	O	3	P	-1

1	Here	Here	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	in	in	B-SBAR	IN	O	6	VMOD	-1
4	order	order	O	NN	O	3	DEP	-1
5	to	to	B-VP	TO	O	6	VMOD	-1
6	characterize	characterize	I-VP	VB	O	34	VMOD	-1
7	the	the	B-NP	DT	O	8	NMOD	-1
8	role	role	I-NP	NN	O	6	OBJ	0
9	of	of	B-PP	IN	O	8	NMOD	-1
10	the	the	B-NP	DT	O	11	NMOD	-1
11	promoter	promoter	I-NP	NN	B-DNA	9	PMOD	-1
12	that	that	B-NP	WDT	O	11	NMOD	-1
13	drives	drive	B-VP	VBZ	O	12	SBAR	0
14	DSCR-1s	DSCR-1s	B-NP	NN	B-protein	15	NMOD	-1
15	expression	expression	I-NP	NN	O	13	OBJ	9	expression
16	in	in	B-PP	IN	O	13	VMOD	-1
17	mediating	mediate	B-VP	VBG	O	16	PMOD	0
18	inducible	inducible	B-NP	JJ	O	19	NMOD	0
19	expression	expression	I-NP	NN	O	17	OBJ	0
20	in	in	B-ADVP	FW	O	19	NMOD	-1
21	vivo	vivo	I-ADVP	FW	O	20	AMOD	-1
22	and	and	O	CC	O	13	VMOD	-1
23	to	to	B-VP	TO	O	24	VMOD	-1
24	determine	determine	I-VP	VB	O	13	VMOD	-1
25	the	the	B-NP	DT	O	27	NMOD	-1
26	functional	functional	I-NP	JJ	O	27	NMOD	-1
27	relevance	relevance	I-NP	NN	O	24	OBJ	-1
28	of	of	B-PP	IN	O	27	NMOD	-1
29	DSCR-1s	DSCR-1	B-NP	NNS	B-protein	28	PMOD	-1
30	in	in	B-PP	IN	O	27	NMOD	-1
31	inflammation	inflammation	B-NP	NN	O	30	PMOD	-1
32	,	,	O	,	O	34	P	-1
33	we	we	B-NP	PRP	O	34	SUB	-1
34	targeted	target	B-VP	VBD	O	0	ROOT	19	targeted
35	a	a	B-NP	DT	O	37	NMOD	-1
36	DNA	DNA	I-NP	NN	B-DNA	37	NMOD	-1
37	construct	construct	I-NP	NN	I-DNA	34	OBJ	-1
38	containing	contain	B-VP	VBG	O	37	NMOD	-1
39	1.7	1.7	B-NP	CD	O	40	NMOD	-1
40	kb	kb	I-NP	NN	O	38	OBJ	-1
41	of	of	B-PP	IN	O	40	NMOD	-1
42	the	the	B-NP	DT	O	45	NMOD	-1
43	human	human	I-NP	JJ	B-DNA	45	NMOD	-1
44	DSCR1s	DSCR1s	I-NP	NN	I-DNA	45	NMOD	-1
45	promoter	promoter	I-NP	NN	I-DNA	41	PMOD	-1
46	coupled	couple	B-VP	VBN	O	40	NMOD	19	coupled
47	to	to	B-PP	TO	O	46	VMOD	-1
48	the	the	B-NP	DT	O	50	NMOD	-1
49	lacZ	lacZ	I-NP	NN	B-DNA	50	NMOD	-1
50	reporter	reporter	I-NP	NN	I-DNA	47	PMOD	-1
51	to	to	B-PP	TO	O	40	NMOD	-1
52	the	the	B-NP	DT	O	60	NMOD	-1
53	hypoxanthine	hypoxanthine	I-NP	NN	B-DNA	60	NMOD	-1
54	guanine	guanine	I-NP	NN	I-DNA	60	NMOD	-1
55	phosphoribosyl	phosphoribosyl	I-NP	NN	I-DNA	60	NMOD	-1
56	transferase	transferase	I-NP	NN	I-DNA	60	NMOD	-1
57	(	(	O	(	I-DNA	60	NMOD	-1
58	Hprt	Hprt	B-NP	NN	I-DNA	60	NMOD	-1
59	)	)	O	)	I-DNA	60	NMOD	-1
60	locus	locus	B-NP	NN	I-DNA	51	PMOD	-1
61	of	of	B-PP	IN	O	60	NMOD	-1
62	mice	mouse	B-NP	NNS	O	61	PMOD	-1
63	.	.	O	.	O	34	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	determined	determine	B-VP	VBD	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	lacZ	lacZ	B-NP	NN	B-DNA	5	SUB	-1
5	was	be	B-VP	VBD	O	3	SBAR	-1
6	uniformly	uniformly	I-VP	RB	O	5	VMOD	-1
7	expressed	express	I-VP	VBN	O	5	VC	9	expressed
8	in	in	B-PP	IN	O	7	VMOD	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	endothelium	endothelium	I-NP	NN	O	8	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	transgenic	transgenic	B-NP	JJ	O	13	NMOD	0
13	embryos	embryo	I-NP	NNS	O	11	PMOD	-1
14	but	but	O	CC	O	5	VMOD	-1
15	was	be	B-VP	VBD	O	5	VMOD	-1
16	markedly	markedly	I-VP	RB	O	15	VMOD	-1
17	downregulated	downregulate	I-VP	VBN	O	15	VC	18	downregulated
18	postnatally	postnatally	B-ADVP	RB	O	17	VMOD	-1
19	.	.	O	.	O	2	P	-1

1	Systemic	Systemic	B-NP	JJ	O	2	NMOD	-1
2	administration	administration	I-NP	NN	O	10	SUB	19	administration
3	of	of	B-PP	IN	O	2	NMOD	-1
4	VEGF	VEGF	B-NP	NN	B-protein	6	NMOD	-1
5	or	or	I-NP	CC	O	6	NMOD	-1
6	LPS	LPS	I-NP	NN	O	3	PMOD	-1
7	in	in	B-PP	IN	O	2	NMOD	-1
8	adult	adult	B-NP	JJ	O	9	NMOD	-1
9	mice	mouse	I-NP	NNS	O	7	PMOD	-1
10	resulted	result	B-VP	VBD	O	0	ROOT	17	resulted
11	in	in	B-PP	IN	O	10	VMOD	-1
12	cyclosporine	cyclosporine	B-NP	NN	O	14	NMOD	-1
13	A-sensitive	A-sensitive	I-NP	JJ	O	14	NMOD	16	sensitive
14	reactivation	reactivation	I-NP	NN	O	22	NMOD	17	reactivation
15	of	of	B-PP	IN	O	14	NMOD	-1
16	the	the	B-NP	DT	O	18	NMOD	-1
17	DSCR1s	DSCR1	I-NP	NNS	B-DNA	18	NMOD	-1
18	promoter	promoter	I-NP	NN	I-DNA	15	PMOD	-1
19	and	and	O	CC	O	22	NMOD	-1
20	endogenous	endogenous	B-NP	JJ	O	22	NMOD	-1
21	gene	gene	I-NP	NN	O	22	NMOD	-1
22	expression	expression	I-NP	NN	O	11	PMOD	0
23	in	in	B-PP	IN	O	22	NMOD	-1
24	a	a	B-NP	DT	O	25	NMOD	-1
25	subset	subset	I-NP	NN	O	23	PMOD	-1
26	of	of	B-PP	IN	O	25	NMOD	-1
27	organs	organ	B-NP	NNS	O	26	PMOD	-1
28	,	,	O	,	O	25	P	-1
29	including	include	B-PP	VBG	O	25	NMOD	-1
30	the	the	B-NP	DT	O	33	NMOD	-1
31	heart	heart	I-NP	NN	O	33	NMOD	-1
32	and	and	I-NP	CC	O	33	NMOD	-1
33	brain	brain	I-NP	NN	O	29	PMOD	-1
34	.	.	O	.	O	10	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	DSCR1s	DSCR1s	I-NP	NN	B-DNA	3	NMOD	-1
3	promoter	promoter	I-NP	NN	I-DNA	4	SUB	-1
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	similarly	similarly	I-VP	RB	O	4	VMOD	-1
6	induced	induce	I-VP	VBN	O	4	VC	17	induced
7	in	in	B-PP	IN	O	6	VMOD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	endothelium	endothelium	I-NP	NN	O	7	PMOD	-1
10	of	of	B-PP	IN	O	9	NMOD	-1
11	tumor	tumor	B-NP	NN	O	12	NMOD	-1
12	xenografts	xenograft	I-NP	NNS	O	10	PMOD	-1
13	.	.	O	.	O	4	P	-1

1	In	In	B-PP	IN	O	10	VMOD	-1
2	a	a	B-NP	DT	O	4	NMOD	-1
3	mouse	mouse	I-NP	NN	O	4	NMOD	-1
4	model	model	I-NP	NN	O	1	PMOD	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	endotoxemia	endotoxemia	B-NP	NN	O	5	PMOD	-1
7	,	,	O	,	O	10	P	-1
8	DSCR-1s-deficient	DSCR-1s-deficient	B-NP	JJ	O	9	NMOD	9	deficient
9	mice	mouse	I-NP	NNS	O	10	SUB	-1
10	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	-1
11	increased	increase	B-NP	VBN	O	13	NMOD	0
12	sepsis	sepsis	I-NP	NN	O	13	NMOD	-1
13	mortality	mortality	I-NP	NN	O	10	OBJ	-1
14	,	,	O	,	O	10	P	-1
15	whereas	whereas	O	IN	O	10	VMOD	-1
16	adenovirus-mediated	adenovirus-mediated	B-NP	JJ	O	18	NMOD	17	mediated
17	DSCR-1s	DSCR-1	I-NP	NNS	O	18	NMOD	-1
18	overexpression	overexpression	I-NP	NN	O	19	SUB	9	overexpression
19	protected	protect	B-VP	VBD	O	15	SBAR	-1
20	against	against	B-PP	IN	O	19	VMOD	0
21	LPS-induced	LPS-induced	B-NP	JJ	O	22	NMOD	-1
22	lethality	lethality	I-NP	NN	O	20	PMOD	-1
23	.	.	O	.	O	10	P	-1

1	Collectively	Collectively	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	these	these	B-NP	DT	O	4	NMOD	-1
4	data	datum	I-NP	NNS	O	5	SUB	-1
5	suggest	suggest	B-VP	VBP	O	0	ROOT	-1
6	that	that	B-SBAR	IN	O	18	DEP	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	DSCR1s	DSCR1s	I-NP	NN	B-DNA	9	NMOD	-1
9	promoter	promoter	I-NP	NN	I-DNA	10	SUB	-1
10	directs	direct	B-VP	VBZ	O	6	SBAR	-1
11	vascular	vascular	B-NP	JJ	O	13	NMOD	-1
12	bed-specific	bed-specific	I-NP	JJ	O	13	NMOD	-1
13	expression	expression	I-NP	NN	O	10	OBJ	9	expression
14	in	in	B-PP	IN	O	10	VMOD	-1
15	activated	activate	B-NP	VBN	O	16	NMOD	17	activated
16	endothelium	endothelium	I-NP	NN	O	14	PMOD	-1
17	and	and	O	CC	O	18	DEP	-1
18	that	that	B-SBAR	IN	O	5	VMOD	-1
19	DSCR-1s	DSCR-1	B-NP	NNS	B-protein	20	SUB	-1
20	serves	serve	B-VP	VBZ	O	18	SBAR	-1
21	to	to	I-VP	TO	O	22	VMOD	-1
22	dampen	dampen	I-VP	VB	O	20	VMOD	-1
23	the	the	B-NP	DT	O	25	NMOD	-1
24	host	host	I-NP	NN	O	25	NMOD	-1
25	response	response	I-NP	NN	O	22	OBJ	0
26	to	to	B-PP	TO	O	25	NMOD	-1
27	infection	infection	B-NP	NN	O	26	PMOD	0
28	.	.	O	.	O	5	P	-1

